These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2840 related articles for article (PubMed ID: 31815570)
1. Contemporary NSTEMI management: the role of the hospitalist. Pollack CV; Amin A; Wang T; Deitelzweig S; Cohen M; Slattery D; Fanikos J; DiLascia C; Tuder R; Kaatz S Hosp Pract (1995); 2020 Feb; 48(1):1-11. PubMed ID: 31815570 [TBL] [Abstract][Full Text] [Related]
2. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies. Lefebvre CW; Hoekstra J Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612 [TBL] [Abstract][Full Text] [Related]
3. API expert consensus document on management of ischemic heart disease. Association of Physicians of India J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697 [TBL] [Abstract][Full Text] [Related]
4. Managing acute coronary syndrome: evidence-based approaches. Spinler SA Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S14-24. PubMed ID: 17519441 [TBL] [Abstract][Full Text] [Related]
5. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678 [TBL] [Abstract][Full Text] [Related]
6. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010]. Silber S Herz; 2010 Dec; 35(8):558-64. PubMed ID: 21107514 [TBL] [Abstract][Full Text] [Related]
7. Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non-ST-Segment Elevation Myocardial Infarction. Silvain J; Rakowski T; Lattuca B; Liu Z; Bolognese L; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimsky P; Miller D; Portal JJ; Collet JP; Vicaut E; Montalescot G; Dudek D; J Am Coll Cardiol; 2019 Mar; 73(8):906-914. PubMed ID: 30819358 [TBL] [Abstract][Full Text] [Related]
8. Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2). Sami S; Willerson JT Tex Heart Inst J; 2010; 37(3):262-75. PubMed ID: 20548800 [TBL] [Abstract][Full Text] [Related]
9. Critical review of prasugrel for formulary decision makers. Schafer JA; Kjesbo NK; Gleason PP J Manag Care Pharm; 2009 May; 15(4):335-43. PubMed ID: 19422273 [TBL] [Abstract][Full Text] [Related]
10. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study. Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731 [TBL] [Abstract][Full Text] [Related]
11. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy. Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G; JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605 [TBL] [Abstract][Full Text] [Related]
12. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Silva MA; Donovan JL; Gandhi PJ; Volturo GA Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468 [TBL] [Abstract][Full Text] [Related]
13. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). Parikh SV; de Lemos JA; Jessen ME; Brilakis ES; Ohman EM; Chen AY; Wang TY; Peterson ED; Roe MT; Holper EM; JACC Cardiovasc Interv; 2010 Apr; 3(4):419-27. PubMed ID: 20398870 [TBL] [Abstract][Full Text] [Related]
14. Outcomes after coronary angiography for unstable angina compared to stable angina, myocardial infarction and an asymptomatic general population. Fladseth K; Wilsgaard T; Lindekleiv H; Kristensen A; Mannsverk J; Løchen ML; Njølstad I; Mathiesen EB; Trovik T; Rotevatn S; Forsdahl S; Schirmer H Int J Cardiol Heart Vasc; 2022 Oct; 42():101099. PubMed ID: 35937948 [TBL] [Abstract][Full Text] [Related]
15. [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports]. Silber S; Richartz BM; Brilmayer M; Herz; 2006 Dec; 31(9):836-46, 848. PubMed ID: 17180646 [TBL] [Abstract][Full Text] [Related]
16. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432 [TBL] [Abstract][Full Text] [Related]
17. Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study. Montalescot G; Collet JP; Ecollan P; Bolognese L; Ten Berg J; Dudek D; Hamm C; Widimsky P; Tanguay JF; Goldstein P; Brown E; Miller DL; LeNarz L; Vicaut E; J Am Coll Cardiol; 2014 Dec; 64(24):2563-2571. PubMed ID: 25524333 [TBL] [Abstract][Full Text] [Related]
18. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence. Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062 [TBL] [Abstract][Full Text] [Related]
19. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction. Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334 [TBL] [Abstract][Full Text] [Related]
20. Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation. Keykhaei M; Ashraf H; Rashedi S; Farrokhpour H; Heidari B; Zokaei S; Bagheri S; Foroumadi R; Asgarian S; Amirian A; Saleh SK; James S Curr Atheroscler Rep; 2021 Oct; 23(12):77. PubMed ID: 34671860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]